Maintenance of natalizumab during the first trimester of pregnancy in active multiple sclerosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Maintenance of natalizumab during the first trimester of pregnancy in active multiple sclerosis
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume -, Issue -, Pages 135245852091263
Publisher
SAGE Publications
Online
2020-03-23
DOI
10.1177/1352458520912637
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pregnancy decision-making in women with multiple sclerosis treated with natalizumab
- (2018) Emilio Portaccio et al. NEUROLOGY
- Pregnancy decision-making in women with multiple sclerosis treated with natalizumab
- (2018) Emilio Portaccio et al. NEUROLOGY
- The role of the placenta in drug transport and fetal drug exposure
- (2018) Gideon Koren et al. Expert Review of Clinical Pharmacology
- Recurrence of disease activity during pregnancy after cessation of fingolimod in multiple sclerosis
- (2017) Ingrid Meinl et al. Multiple Sclerosis Journal
- Recurrence of disease activity during pregnancy after cessation of fingolimod in multiple sclerosis
- (2017) Ingrid Meinl et al. Multiple Sclerosis Journal
- Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study
- (2016) Susan Friend et al. BMC Neurology
- Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning
- (2016) Vittorio Martinelli et al. Multiple Sclerosis Journal
- Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning
- (2016) Vittorio Martinelli et al. Multiple Sclerosis Journal
- Natalizumab discontinuation and disease restart in pregnancy: a case series
- (2015) L. De Giglio et al. ACTA NEUROLOGICA SCANDINAVICA
- Normal outcome of pregnancy with ongoing treatment with natalizumab
- (2014) J. Fagius et al. ACTA NEUROLOGICA SCANDINAVICA
- Épidémiologie des pertes de grossesse
- (2014) A. Delabaere et al. JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION
- Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study
- (2014) Neda Ebrahimi et al. Multiple Sclerosis Journal
- Natalizumab Use During the Third Trimester of Pregnancy
- (2014) Aiden Haghikia et al. JAMA Neurology
- Natalizumab treatment during pregnancy - effects on the neonatal immune system
- (2012) H. Schneider et al. ACTA NEUROLOGICA SCANDINAVICA
- Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment
- (2011) Kerstin Hellwig et al. Multiple Sclerosis Journal
- Delivery of healthy babies after natalizumab use for multiple sclerosis: a report of two cases
- (2010) I. A. Hoevenaren et al. ACTA NEUROLOGICA SCANDINAVICA
- Embryo/fetal development in cynomolgus monkeys exposed to natalizumab, an α4 integrin inhibitor
- (2009) Nancy G. Wehner et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- Effects of natalizumab, an α4 integrin inhibitor, on the development of Hartley guinea pigs
- (2009) Nancy G. Wehner et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- Réseau sentinelle Audipog 2004–2005. Partie 1 : résultats des principaux indicateurs périnatals
- (2008) F. Vendittelli et al. GYNECOLOGIE OBSTETRIQUE & FERTILITE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now